Lenvatinib as Second-Line Treatment in Patients With Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

Lenvatinib as Second-Line Treatment in Patients With Unresectable Hepatocellular Carcinoma: A Retrospective Analysis

header-info

The purpose of this study is to determine the efficacy and safety of lenvatinib as second-line therapy in Chinese patients with unresectable hepatocellular carcinoma (HCC).